02/02/2017 - 3:28pm

Generics have made a huge difference to the U.S. healthcare system’s bottom line in the past decade, a savings that takes 13 figures to tabulate.

02/02/2017 - 3:27pm

The emergence of new products across the cough-cold and allergy categories is transforming the OTC aisle.

02/02/2017 - 11:20am

U.S. comp-store sales enjoy 6% rise in four-week period ended Jan. 29.

02/02/2017 - 10:59am

Winter weather events, a slow cold and flu season and continued reimbursement pressure affected overall sales for Q4, fiscal year 2016 and January, however.

01/31/2017 - 1:35pm

Evercore ISI’s Ross Muken has reiterated his “buy” rating on Walgreens stock.

01/30/2017 - 2:08pm

Antitrust policy in the Trump Administration is uncertain however, states financial firm.

01/30/2017 - 10:04am

Under the terms of the amendment, Walgreens Boots Alliance will pay a maximum of $7 per share, down from $9 per share, and the end date is extended from Jan. 27 to July 31.

01/27/2017 - 4:39pm

Citing sources close to the negotiations, The New York Post on Friday reported that private-equity giant Cerberus Capital may emerge as a possible white knight for Walgreens and Rite Aid by acquiring the 865 stores being divested. "Cerberus had participated in Walgreen’s December auction of the stores in question, losing to a winning bid of $950 million from regional drug chain Fred’s, according to two sources close to the situation," The Post reported. "Walgreens had rejected Cerberus’ bid partly because it was concerned the Federal Trade Commission would not approve a private-equity buyer, according to the sources." Either way, the deal is "not in danger of collapsing" even though the deal technically expires Friday, The Post added. (The New York Post)

01/27/2017 - 11:46am

Summer’s Eve, Fleet and Pedia-Lax among acquired brands.